Carbonic anhydrase VA deficiency: a very rare case of hyperammonemic encephalopathy.
CA5A gene
carbonic anhydrase VA deficiency
hyperammonemia
metabolic acidosis
Journal
Journal of pediatric endocrinology & metabolism : JPEM
ISSN: 2191-0251
Titre abrégé: J Pediatr Endocrinol Metab
Pays: Germany
ID NLM: 9508900
Informations de publication
Date de publication:
18 Aug 2020
18 Aug 2020
Historique:
received:
12
03
2020
accepted:
22
05
2020
pubmed:
19
8
2020
medline:
16
6
2021
entrez:
19
8
2020
Statut:
epublish
Résumé
Objectives Carbonic anhydrase VA (CAVA) deficiency is a rare autosomal recessive inborn error of metabolism that leads to acute metabolic crises, especially in the neonatal or infantile period. It is caused by a deficiency of the enzyme CAVA, which is encoded by the CA5A gene. Case presentation Fifteen patients with homozygous pathogenic CA5A mutations involving 10 different lesions have been reported in the literature up to date. Main clinical and biochemical features of CAVA deficiency include lethargy, hyperammonemic encephalopathy, metabolic acidosis, elevated lactate and hypoglycemia. In most patients reported so far, a single metabolic decompensation attack has been reported, and they have remained stable thereafter with no further crisis. Conclusions We report the 16th case of CAVA deficiency, who was diagnosed by whole-exome sequencing and showed a typical course of the disease with normal development at 18 months.
Identifiants
pubmed: 32809955
doi: 10.1515/jpem-2020-0117
pii: /j/jpem.ahead-of-print/jpem-2020-0117/jpem-2020-0117.xml
doi:
pii:
Substances chimiques
Carbonic Anhydrase V
EC 4.2.1.-
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM